Fonte: Nutrients. Unidade: FSP
Assuntos: GLUTAMATOS, GLUTAMINA, INFLAMAÇÃO, DEPRESSÃO, DOENÇAS NEURODEGENERATIVAS, DEGENERAÇÃO NEURAL, TRANSTORNOS NEUROPSICOLÓGICOS
ABNT
MCGRATH, Thomas et al. Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases. Nutrients, v. 14, n. 5, p. art. 917 [27], 2022Tradução . . Disponível em: https://doi.org/10.3390/nu14050917. Acesso em: 28 ago. 2024.APA
McGrath, T., Baskerville, R., Rogero, M. M., & Castell, L. (2022). Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases. Nutrients, 14( 5), art. 917 [27]. doi:10.3390/nu14050917NLM
McGrath T, Baskerville R, Rogero MM, Castell L. Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases [Internet]. Nutrients. 2022 ;14( 5): art. 917 [27].[citado 2024 ago. 28 ] Available from: https://doi.org/10.3390/nu14050917Vancouver
McGrath T, Baskerville R, Rogero MM, Castell L. Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases [Internet]. Nutrients. 2022 ;14( 5): art. 917 [27].[citado 2024 ago. 28 ] Available from: https://doi.org/10.3390/nu14050917